close Icon

Research
at Burnet

At Burnet, we are actively working towards a healthier world - one where all people have access to life-changing research and health programs, no matter their status, location or background. Discover our areas of research below.

Research
at Burnet

At Burnet, we are actively working towards a healthier world - one where all people have access to life-changing research and health programs, no matter their status, location or background. Discover our areas of research below.

Technical
Focuses

Our point of difference is our technical breadth – from laboratory-based discoveries to field research, and commercialisation to development programs, we are working towards better health for all people.

Discovery + Translation

We are committed to strengthening health systems in collaboration with Government and non-Government organisations and communities.

Community Engagement

We work in partnership with people and affected communities to bring about sustainable change. 

Epidemiology

Our epidemiological studies help inform policy and practice, and provide evidence-based recommendations to governments on how to reduce or prevent disease.

Health Systems

We are committed to strengthening health systems in collaboration with Government and non-Government organisations and communities. 

Data + Modelling

We are at the forefront of modelling across areas including COVID-19, hepatitis C and B, HIV, tuberculosis, malaria, nutrition, and maternal, newborn and child health.

Implementation

We develop, test, and evaluate new tools, interventions, and programs to address public health needs, with an emphasis on innovation, equity, and sustainability. 

Core
Programs

Three institute-wide interdisciplinary thematic health programs represent the breadth of our technical skill base and foster a collaborative approach to tackling challenging global health issues.

Disease Elimination
PROGRAM Disease Elimination
Health Security and Pandemic Preparedness
PROGRAM Health Security and Pandemic Preparedness
Women’s, Children’s and Adolescents’ Health
PROGRAM Women’s, Children’s and Adolescents’ Health

Flagship Initiatives

Eliminate Hepatitis C Australia (EC Australia)
FLAGSHIP INITIATIVES Eliminate Hepatitis C Australia (EC Australia)
Burnet Diagnostics Initiative (BDI)
FLAGSHIP INITIATIVES Burnet Diagnostics Initiative (BDI)
Know-C19
FLAGSHIP INITIATIVES Know-C19
Healthy Mothers, Healthy Babies (HMHB)
FLAGSHIP INITIATIVES Healthy Mothers, Healthy Babies (HMHB)

Communities

We work to achieve better health for vulnerable communities in Australia and internationally.

VIEW ALL
COMMUNITY

Aboriginal + Torres Strait Islander Peoples

VIEW COMMUNITY
COMMUNITY

Adolescents + Young People

VIEW COMMUNITY
COMMUNITY

Children + Newborns

VIEW COMMUNITY
COMMUNITY

Culturally + Linguistically Diverse [CALD]

VIEW COMMUNITY
COMMUNITY

Families

VIEW COMMUNITY
COMMUNITY

LGBTQIA+

VIEW COMMUNITY

Working Groups

View all Working Groups
Alcohol and Other Drugs Group

Co-Heads: Professor Paul Dietze and Associate Professor Peter Higgs. Alcohol and other drug use is a...

GROUP VIEW GROUP
Burnet Diagnostics Initiative (BDI)

Director: Jennifer Barnes. Scientific Director: Professor Heidi Drummer. Our working group is a comm...

GROUP VIEW GROUP
Diagnostic Markers in Chronic Immune Disorders Group

Head: Dr Raffi Gugasyan. Understanding the role of key signalling molecules that are critical for th...

GROUP VIEW GROUP
Global Adolescent Health Group

Co Heads: Dr Elissa Kennedy and Dr Julie Hennegan. Adolescence as a key developmental stage within t...

GROUP VIEW GROUP
Global Health: policy, practice and community action

Co Heads: Mr Chad Hughes and Ms Lisa Davidson. We translate research into sustainable health solutio...

GROUP VIEW GROUP
Global Women's and Newborn's Health Group

Co-Heads: Professor Caroline Homer and Professor Joshua Vogel. Improving the health and well-being o...

GROUP VIEW GROUP

Latest
Research

Explore our library of peer-reviewed publications with contributions from Burnet researchers.

VIEW ALL RESEARCH
Stellabody®: A novel hexamer-promoting mutation for improved IgG potency
  • 04 Oct 2024
Immune Disease + Cancer Stellabody®: A novel hexamer-promoting mutation for improved IgG potency
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extracellular pH.

Fraser JE, Rawlinson SM, Heaton SM, Jans DA

  • 29 Aug 2024
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extracellular pH.
20-year trends in Australian methamphetamine-related deaths, 2001-2020.

Stronach O, Dietze P, Livingston M, Roxburgh A

  • The International journal on drug policy
  • 13 Aug 2024
Alcohol + Other Drugs 20-year trends in Australian methamphetamine-related deaths, 2001-2020.
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.

Howell J, Combo T, Binks P, Bragg K, Bukulatjpi S, Campbell K, Clark PJ, Carroll M, Davies J, de Santis T, Muller KR, Nguyen B, Olynyk JK, Shackel N, Valery PC, Wigg AJ, George J, Roberts SK

  • The Medical journal of Australia
  • 06 Aug 2024
Alcohol + Other Drugs Hepatitis B Hepatitis C Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.
GALV-KoRV-related retroviruses in diverse Australian and African rodent species.

Hayward JA, Tian S, Tachedjian G

  • Virus evolution
  • 31 Jul 2024
GALV-KoRV-related retroviruses in diverse Australian and African rodent species.
Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review.

Bell S, Gibbs S, Winskell A, Villarino X, Gill H, Little K

  • Reproductive health
  • 28 Jun 2024
Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review.